Learn what ciprofloxacin is good for, when to use it, what are the side effects of ciprofloxacin, and when to choose another antibiotic. Ciprofloxacin is the go-to antibiotic for the treatment of urinary tract infections (UTIs) like acute pyelonephritis and prostatitis, respiratory infections like pneumonia, and many other infections. Is this antibiotic really that good, or should we change something, and WHY? Every clinician has to be able to recognize life-threatening infections like sepsis and CNS infections right away! This free online course teaches you just that! If you work with patients, don't put this off! You will need what you learn in this course the very next shift! A Clinical Approach to Serious Infections in Adults: What Every Physician Should Know: https://drviktorkotarski.podia.com/recognize-serious-infections-early DISCLAIMER: Please keep in mind that my videos are intended for educational purposes only. The content of my videos is NOT medical advice. I do not practice medicine over the Internet. If you are a patient and have any questions about your health, please talk to your doctor. CHAPTERS: 00:00 What we use ciprofloxacin for 00:45 Ciprofloxacin for UTIs 02:31 Ciprofloxacin for pneumonia 03:39 Ciprofloxacin for skin infections 04:01 Side effects of ciprofloxacin REFERENCES & RECOMMENDED READING: 1. Gupta K, Hooton TM, Naber KG, Wullt B, Colgan R, Miller LG, et al. International clinical practice guidelines for the treatment of acute uncomplicated cystitis and pyelonephritis in women: A 2010 update by the Infectious Diseases Society of America and the European Society for Microbiology and Infectious Diseases. Clin Infect Dis. 2011 Mar 1;52(5):e103-120. 2. Uroweb - European Association of Urology [Internet]. [cited 2024 Mar 7]. EAU Guidelines on Urological Infections - THE GUIDELINE - Uroweb. Available from: https://uroweb.org/guidelines/urological-infections/chapter/the-guideline 3. Joshua PM Grant W Waterer, Ann C Long, Antonio Anzueto, Jan Brozek, Kristina Crothers, Laura A Cooley, Nathan C Dean, Michael J Fine, Scott A Flanders, Marie R Griffin, Mark L Metersky, Daniel M Musher, Marcos I Restrepo, and Cynthia G Whitney; on behalf of the American Thoracic Society and Infectious Diseases Society of. Diagnosis and Treatment of Adults with Community-acquired Pneumonia. An Official Clinical Practice Guideline of the American Thoracic Society and Infectious Diseases Society of America [Internet]. [cited 2024 Mar 7]. Available from: https://www.idsociety.org/practice-guideline/community-acquired-pneumonia-cap-in-adults/ 4. Overview | Pneumonia (community-acquired): antimicrobial prescribing | Guidance | NICE [Internet]. 2020 [cited 2020 Jan 16]. Available from: https://www.nice.org.uk/guidance/ng138 5. Antimicrobial resistance surveillance in Europe 2022 - 2020 data [Internet]. 2022 [cited 2024 Mar 7]. Available from: https://www.ecdc.europa.eu/en/publications-data/antimicrobial-resistance-surveillance-europe-2022-2020-data 6. Fluoroquinolone antibiotics: reminder of measures to reduce the risk of long-lasting, disabling and potentially irreversible side effects | European Medicines Agency [Internet]. [cited 2024 Mar 7]. Available from: https://www.ema.europa.eu/en/news/fluoroquinolone-antibiotics-reminder-measures-reduce-risk-long-lasting-disabling-and-potentially-irreversible-side-effects